Researcher from Martin-Luther-University Halle-Wittenberg Details New Studies and Findings in the Area of T-Cell Lymphoma (SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters).

Předmět:
Zdroj: Hematology Week; 6/20/2023, p2112-2112, 1p
Abstrakt: Alkylating Agents, Antineoplastics, Cancer, Drugs and Therapies, Health and Medicine, Hematology, Immunoproliferative Disorders, Lymphatic Diseases and Conditions, Lymphoma, Lymphoproliferative Disorders, Oncology, Oxaliplatin Therapy, Pharmaceuticals, Pharmacology, T-Cell Lymphoma, Therapy Keywords: Alkylating Agents; Antineoplastics; Cancer; Drugs and Therapies; Health and Medicine; Hematology; Immunoproliferative Disorders; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Oncology; Oxaliplatin Therapy; Pharmaceuticals; Pharmacology; T-Cell Lymphoma; Therapy EN Alkylating Agents Antineoplastics Cancer Drugs and Therapies Health and Medicine Hematology Immunoproliferative Disorders Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Oncology Oxaliplatin Therapy Pharmaceuticals Pharmacology T-Cell Lymphoma Therapy 2112 2112 1 06/19/23 20230620 NES 230620 2023 JUN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Fresh data on T-cell lymphoma are presented in a new report. [Extracted from the article]
Databáze: Complementary Index